Prolonged severe hypotension following combined amlodipine and valsartan ingestion

References

• Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM. 2005 Annual Report of the American Association of Poison Control Centers’ National Poisoning and Exposure Database. Clin Toxicol 2006; 44: 803–932
   PubMed Web of Science ®Google Scholar
• Abernethy DR. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992; 80(Suppl 1)31–6
   PubMedGoogle Scholar
• Vogt S, Mehlig A, Hunziker P, Scholer A, Jung J, Baranda A, González A, Weinmann W, Marsc S. Survival of severe amlodipine intoxication due to medical intensive care. Forensic Sci Int 2006; 161: 216–20
   PubMed Web of Science ®Google Scholar
• Adams BD, Browne WT. Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am J Emerg Med 1998; 16: 527–8
   PubMed Web of Science ®Google Scholar
• McFarlane SI, Kumar A, Sowers JR. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol 2003; 91: 30H–37H
   PubMed Web of Science ®Google Scholar
• Black HR. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: A review of mechanistic and clinical data. Am Heart J 2004; 147: 564–72
   PubMed Web of Science ®Google Scholar
• Brabant SM, Eyraud D, Bertrand M, Coriat P. Refractory Hypotension After Induction of Anesthesia in a Patient Chronically Treated with Angiotensin Receptor Antagonists. Anesth Analg 1999; 89: 887–8
   PubMed Web of Science ®Google Scholar
• Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR. Long-term Angiotensin-converting Enzyme Inhibitor Treatment Attenuates Adrenergic Responsiveness without Altering Hemodynamic Control in Patients Undergoing Cardiac Surgery. Anesthesiology 1996; 84: 789–800
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344: 1721–2
   PubMed Web of Science ®Google Scholar
• Cosbey SH, Carson DJ. A fatal case of amlodipine poisoning. J Anal Toxicol 1997; 2: 221–2
   Google Scholar
• Feldman R, Glinska-Serwin M. Gleboka hipotensja z przemijajaca oliguria oraz ciezka niewydolnosc serca w przebiegu ostrego zamierzonego zatrucia amlodypina. [Deep hypotension with transient oliguria and severe heart failure in course of acute intentional poisoning with amlodipine]. Pol Arch Med Wewn 2001; 105: 495–9
   PubMedGoogle Scholar
• Harris NS. Case records of the Massachusetts General Hospital. Case 24–2006. A 40-year-old woman with hypotension after an overdose of amlodipine. N Engl J Med 2006; 355: 602–11
   PubMed Web of Science ®Google Scholar
• Johansen SS, Genner J. A fatal case of amlodipine poisoning. J Clin Forensic Med 2003; 10: 169–172
   PubMedGoogle Scholar
• Koch AR, Vogelaers DP, Decruyenaere JM, Callens B, Verstraete A, Buylaert WA. Fatal intoxication with amlodipine. J Toxicol Clin Toxicol 1995, 33: 253–6
   Google Scholar
• Rasmussen L, Husted SE, Johnsen SP. Severe intoxication after an intentional overdose of amlodipine. Acta Anaesthesiol Scand 2003; 47: 1038–40
   PubMed Web of Science ®Google Scholar
• Saravu K, Balasubramanian R. Near-fatal amlodipine poisoning. J Assoc Physicians India 2004; 52: 156–7
   PubMedGoogle Scholar
• Stanek EJ, Nelson CE, DeNofrio D. Amlodipine overdose. Ann Pharmacother 1997; 31: 853–6
   PubMed Web of Science ®Google Scholar
• Tovar JL, Bujons I, Ruiz JC, Ibanez L, Salgado A. Treatment of severe combined overdose of calcium antagonists and converting enzyme inhibitors with angiotensin II. Nephron 1997; 77(2)239
   PubMedGoogle Scholar
• Weisgerber K, Link A, Hammer B, Bohm M. Vasopressinanaloga als ultima ratio bei einer schweren intoxikation mit vasodilatanzien. [Vasopressin analogue injection as ultimate measure for counteracting severe catecholamine-refractory poisoning by several vasodilators taken with suicidal intent]. Dtsch Med Wochenschr 2003; 128: 2189–92
   PubMed Web of Science ®Google Scholar
• Wood DM, Wright KD, Jones AL, Dargan PI. Metaraminol (Aramine) in the management of a significant amlodipine overdose. Hum Exp Toxicol 2005; 24: 377–81
   PubMed Web of Science ®Google Scholar
• Yuan TH, Kerns WP, 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 1999; 37: 463–74
   PubMed Web of Science ®Google Scholar
• Lenasi H, Kohlstedt K, Fichtlscherer B, Mulsch A, Busse R, Fleming I. Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovasc Res 2003; 59: 844–53
   PubMed Web of Science ®Google Scholar
• Xu B, Xiao-hong L, Lin G, Queen L, Ferro A. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br J Pharmacol 2002; 136: 375–82
   PubMed Web of Science ®Google Scholar
• Eyraud D, Brabant S, Nathalie D, Fleron MH, Gilles G, Bertrand M, Coriat P. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 1999; 88: 980–4
   PubMed Web of Science ®Google Scholar
• Howarth DM, Dawson AH, Smith AJ, Buckley NA, Whyte IM. Calcium channel blocking drugs in overdose: an Australian series. Hum Exp Toxicol 1994; 13: 161–6
   PubMed Web of Science ®Google Scholar
• Buckley NA, Whyte IM, Dawson AH. Overdose with Calcium Channel Blockers BMJ. 1994; 308: 1639
   Google Scholar
• Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26: 65–79
   PubMed Web of Science ®Google Scholar
• Sauvadet A, Rohn T, Pecker F, Pavoine C. Arachidonic acid drives mini-glucagon action in cardiac cells. J Biol Chem 1997; 272: 12437–45
   PubMed Web of Science ®Google Scholar
• Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res 1997; 34: 289–98
   PubMed Web of Science ®Google Scholar
• Marques M, Gomes E, de Oliveira J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation 2003; 57: 211–3
   PubMed Web of Science ®Google Scholar
• Koskenkari JK. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 2005; 80: 511–7
   PubMed Web of Science ®Google Scholar
• Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg 2003; 75: S721–8
   PubMed Web of Science ®Google Scholar
• Svedjeholm R, Ekroth R, Joachimsson PO, Tyden H. High-dose insulin improves the efficacy of dopamine early after cardiac surgery. A study of myocardial performance and oxygen consumption. Scand J Thorac Cardiovasc Surg 1991; 25: 215–21
   PubMed Web of Science ®Google Scholar
• Prigeon RL, Roder ME, Porte D, Jr, Kahn SE. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest 1996; 97: 501–7
   PubMed Web of Science ®Google Scholar
• Mokshagundam SP, Peiris AN, Stagner JI, Gingerich RL, Samols E. Interstitial insulin during euglycemic-hyperinsulinemic clamp in obese and lean individuals. Metabolism 1996; 45: 951–6
   PubMed Web of Science ®Google Scholar
• Kline JA, Leonova E, Williams TC, Schroeder JD, Watts JA. Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol 1996; 27: 719–26
   PubMed Web of Science ®Google Scholar
• Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997; 145: 357–62
   PubMed Web of Science ®Google Scholar
• Miller AD, Maloney GE, Kanter MZ, Clifton JC, DesLauriers CA. Are poison center recommendations for high-dose insulin treatment in calcium-channel blocker poisoning patients followed [Abstract]. Clin Toxicol 2006; 44: 711
   Web of Science ®Google Scholar
• Qi YM, Yang DJ, Duan X, Yang F, Li SR, Shen JM, Wang R. Endomorphins inhibit contractile responses of rat thoracic aorta rings induced by phenylephrine and angiotensin II in vitro. Acta Pharmacol Sin 2002; 23: 40–4
   PubMed Web of Science ®Google Scholar
• Montastruc P, Dang-Tran L, Carvajal A, Rostin M, Montastruc JL. Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation. Neuropeptides 1985; 6: 537–42
   PubMed Web of Science ®Google Scholar
• Millar JA, Sturani A, Rubin PC, Lawrie C, Reid JL. Attenuation of the antihypertensive effect of captopril by the opioid receptor antagonist naloxone. Clin Exp Pharmacol Physiol 1983; 10: 253–9
   PubMed Web of Science ®Google Scholar
• Ajayi AA, Campbell BC, Rubin PC, Reid JL. Effect of naloxone on the actions of captopril. Clin Pharmacol Ther 1985; 38: 560–5
   PubMed Web of Science ®Google Scholar
• Varon J, Duncan SR. Naloxone reversal of hypotension due to captopril overdose. Ann Emerg Med 1991; 20: 1125–7
   PubMed Web of Science ®Google Scholar
• Barr CS, Payne R, Newton RW. Profound prolonged hypotension following captopril overdose. Postgrad Med J 1991; 67: 953–4
   PubMed Web of Science ®Google Scholar
• Boccara G, Ouattara A, Godet G, Dufresne E, Bertrand M, Riou B, Coriat P. Terlipressin Versus Norepinephrine to Correct Refractory Arterial Hypotension after General Anesthesia in Patients Chronically Treated with Renin-Angiotensin System Inhibitors. Anesthesiology 2003; 98: 1338–44
   PubMed Web of Science ®Google Scholar
• McNamee JJ, Trainor D, Michalek P. Terlipressin for refractory hypotension following angiotensin-II receptor antagonist overdose. Anaesthesia 2006; 61: 408–9
   PubMed Web of Science ®Google Scholar
• Sztajnkrycer MD, Bond GR, Johnson SB, Weaver AL. Use of vasopressin in a canine model of severe verapamil poisoning: a preliminary descriptive study. Acad Emerg Med 2004; 11: 1253–61
   PubMed Web of Science ®Google Scholar
• Leone M, Charvet A, Delmas A, Albanese J, Martin C, Boyle WA. Terlipressin: a new therapeutic for calcium-channel blockers overdose. J Crit Care 2005; 20: 114–5
   PubMed Web of Science ®Google Scholar